Biologics

Biologics development company AgeX Therapeutics added Michael May, PhD, to its board of directors, returning it to full strength.

Chad Kurtenbach, MD, of Sioux Falls, S.D.-based Sanford Health is conducting a study of a stem cell treatment for patients with osteoarthritis in the knee.

Biologics has the potential to be the next transformative tool in the orthopedic surgeon's playbook, but the field still has a ways to go before it becomes a mainstream medicinal offering.

Health plan provider Gilsbar entered into a partnership with interventional orthopedic clinic network Regenexx to provide beneficiaries access to reduced-cost musculoskeletal care options.

The California Institute for Regenerative Medicine was never supposed to last infinitely, but a new ballot initiative could extend its lifespan, Nature reports.

NanoFuse released NanoStrip, a glass synthetic biologic strip clinicians can use in spine and orthopedic procedures.

The FDA approved Personalized Stem Cells' new drug application for its adipose-derived stem cell-based osteoarthritis treatment.

A team of UC Irvine researchers developed a mesenchymal stem cell-based treatment that can identify and kill bone cancer metastases in mice, the Daily Pilot reports.

Adam Rivadeneyra, MD, a sports medicine specialist with Irvine, Calif.-based Hoag Orthopedic Institute, spoke to Becker's Spine Review about his predictions for the field of biologics.

NanoFuse Biologics expanded into Asia after the successful use of its technology in a patient suffering from degenerative spine disease and osteoporosis in Thailand.